---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-057853"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2022-02-28T23:59:59+00:00"
generated_at: "2026-06-27T03:41:57.811127+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bioventus appoints Mark Singleton as CFO effective March 21, 2022, succeeding Gregory Anglum

## Summary
- Mark Singleton appointed CFO, effective March 21, 2022; joins from Teleflex Inc.
- Base salary of $430,000, annual bonus target 50% of base salary.
- Initial equity grants: 74,500 RSUs and options for 223,200 shares, vesting over 4 years.
- Cash buyout of unvested Teleflex equity of $81,943; plus sign-on cash for unpaid 2021 bonus.
- Former CFO Gregory Anglum to remain through April 2022 to assist transition.

## SEC filing metadata
- accession: 0001193125-22-057853
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2022-02-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000119312522057853/0001193125-22-057853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000119312522057853/d151986d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-057853
- JSON: https://secwatch.observer/filing/0001193125-22-057853.json
- Plain text: https://secwatch.observer/filing/0001193125-22-057853.txt

## Key facts
- Executive change
  Mark Singleton was appointed as Senior Vice President, Chief Financial Officer and principal accounting officer at Bioventus Inc..
  - Action: appointed
  - Role: Senior Vice President, Chief Financial Officer and principal accounting officer
  source text: On February 28, 2022, Bioventus Inc. (the “Company”) announced that Mark Singleton has been appointed as the Company’s Senior Vice President, Chief Financial Officer and principal accounting officer, effective March 21, 2022, succeeding Gregory Anglum in such role.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312522057853/0001193125-22-057853-index.htm
- Executive change
  Gregory Anglum departed as Chief Financial Officer at Bioventus Inc..
  - Action: departed
  - Role: Chief Financial Officer
  source text: Mr. Anglum is expected to remain employed with the Company through April 2022, to assist with the transition.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312522057853/0001193125-22-057853-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.